Reduced quantity and function of pneumococcal antibodies are associated with exacerbations of COPD in SPIROMICS.
Reduced quantity and function of pneumococcal antibodies are associated with exacerbations of COPD in SPIROMICS. Clin Immunol. 2023 05; 250:109324.